Isolated Limb Perfusion
- 1 October 2001
- journal article
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 10 (4) , 821-832
- https://doi.org/10.1016/s1055-3207(18)30034-6
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Hyperthermic isolated regional perfusion of the limb with carboplatinEuropean Journal of Surgical Oncology, 2000
- Isolated limb perfusion with tumour necrosis factor-α and melphalan for unresectable bone sarcomas of the lower extremityEuropean Journal of Surgical Oncology, 1999
- Die isolierte hypertherme Extremitätenperfusion beim malignen Melanom mit Melphalan und TumornekrosefaktorDeutsche Medizinische Wochenschrift (1946), 1997
- Hyperthermic isolated limb perfusion with cisplatin in four patients with sarcomas of soft tissue and boneEuropean Journal of Surgical Oncology, 1996
- Systemic toxicity after isolated limb perfusion with melphalan for melanomaEuropean Journal of Surgical Oncology, 1996
- A single centre's 10 year experience with isolated limb perfusion in the treatment of recurrent malignant melanoma of the limbEuropean Journal Of Cancer, 1996
- A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremitiesEuropean Journal Of Cancer, 1995
- High dose recombinant tumour necrosis factor (rTNFα) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancerEuropean Journal Of Cancer, 1995
- Results of a double perfusion schedule with melphalan in patients with melanoma of the lower limbEuropean Journal Of Cancer, 1993
- Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactionsEuropean Journal of Cancer and Clinical Oncology, 1982